ASX companies begin to show revenue from cannabis sales
ASX medical cannabis companies show their financial standing in their recently published half-yearly reports.
Botanix receives endorsement by American Academy of Dermatology
Botanix is currently running medicinal cannabis Phase 2 clinical trials on acne and atopic dermatitis, and Phase 1B on psoriasis.
BOD Australia expands medicinal cannabis product range.
With the supply of a 1:1 capsule for a clinical trial on Tourette's Syndrome.
Medicinal cannabis patient registrations open in Thailand
Patients can now register with the FDA for legal possession without being punished.
Research uncovers targeted pathway for treatment of breast cancer.
Growing evidence of THC as a treatment option for HER2+ breast cancer.
MedMen release captivating Spike Jonze and Jesse Williams cannabis commercial
The 2-minute commercial is part of MedMens 'The New Normal' marketing campaign.
MGC Pharma confirms highest-THC cannabis strain.
MGC Pharmaceuticals (ASX: MXC) (OTC: MGCLF) has announced confirmation that...
AusCann appoints new CEO
AusCann (ASX: AC8) has announced the appointment of Mr Ido...
Medicinal cannabis suppositories aren’t a joke for everyone.
Cannabis suppositories are becoming a popular method to treat digestive and urinary issues.
Countries make big steps towards medicinal cannabis.
Recently, several countries have made moves on medicinal cannabis.